92 related articles for article (PubMed ID: 8060750)
1. Oncogene expression in cervical cancer.
Baker VV
Cancer Treat Res; 1994; 70():43-51. PubMed ID: 8060750
[TBL] [Abstract][Full Text] [Related]
2. Proto-oncogenes and prognosis in early carcinoma of the uterine cervix.
Riou GF
Cancer Surv; 1988; 7(3):441-56. PubMed ID: 2853996
[TBL] [Abstract][Full Text] [Related]
3. [c-myc and c-Ha-ras proto-oncogenes in cervical cancer: prognostic value].
Riou G; Sheng ZM; Zhou D; Lusinchi A; Le Doussal V; Barrois M
Bull Cancer; 1990; 77(4):341-7. PubMed ID: 2191730
[TBL] [Abstract][Full Text] [Related]
4. Oncogene expression and prognosis in cervical cancer.
Pillai R
Cancer Lett; 1991 Aug; 59(2):171-5. PubMed ID: 1884374
[TBL] [Abstract][Full Text] [Related]
5. Genetic alterations in cervical carcinomas: frequent low-level amplifications of oncogenes are associated with human papillomavirus infection.
Zhang A; Månér S; Betz R; Angström T; Stendahl U; Bergman F; Zetterberg A; Wallin KL
Int J Cancer; 2002 Oct; 101(5):427-33. PubMed ID: 12216070
[TBL] [Abstract][Full Text] [Related]
6. Radiation-enhanced expression of E6/E7 transforming oncogenes of human papillomavirus-16 in human cervical carcinoma.
Santin AD; Hermonat PL; Ravaggi A; Chiriva-Internati M; Pecorelli S; Parham GP
Cancer; 1998 Dec; 83(11):2346-52. PubMed ID: 9840534
[TBL] [Abstract][Full Text] [Related]
7. Oncogene protein co-expression. Value of Ha-ras, c-myc, c-fos, and p53 as prognostic discriminants for breast carcinoma.
Bland KI; Konstadoulakis MM; Vezeridis MP; Wanebo HJ
Ann Surg; 1995 Jun; 221(6):706-18; discussion 718-20. PubMed ID: 7794075
[TBL] [Abstract][Full Text] [Related]
8. Association of p27Kip1, cyclin E and c-myc expression with progression and prognosis in HPV-positive cervical neoplasms.
Dellas A; Schultheiss E; Leivas MR; Moch H; Torhorst J
Anticancer Res; 1998; 18(6A):3991-8. PubMed ID: 9891436
[TBL] [Abstract][Full Text] [Related]
9. The prognostic value of HER-2/neu oncogene in cervical cancer.
Ndubisi B; Sanz S; Lu L; Podczaski E; Benrubi G; Masood S
Ann Clin Lab Sci; 1997; 27(6):396-401. PubMed ID: 9433536
[TBL] [Abstract][Full Text] [Related]
10. Genetic alterations at 5p15: a potential marker for progression of precancerous lesions of the uterine cervix.
Mitra AB; Murty VV; Singh V; Li RG; Pratap M; Sodhani P; Luthra UK; Chaganti RS
J Natl Cancer Inst; 1995 May; 87(10):742-5. PubMed ID: 7563151
[TBL] [Abstract][Full Text] [Related]
11. The presence of human papillomavirus-16/-18 E6, p53, and Bcl-2 protein in cervicovaginal smears from patients with invasive cervical cancer.
Pillai MR; Halabi S; McKalip A; Jayaprakash PG; Rajalekshmi TN; Nair MK; Herman B
Cancer Epidemiol Biomarkers Prev; 1996 May; 5(5):329-35. PubMed ID: 9162297
[TBL] [Abstract][Full Text] [Related]
12. High correlation between molecular alterations of the c-myc oncogene and carcinoma of the uterine cervix.
Ocadiz R; Sauceda R; Cruz M; Graef AM; Gariglio P
Cancer Res; 1987 Aug; 47(15):4173-7. PubMed ID: 3300961
[TBL] [Abstract][Full Text] [Related]
13. The role of ras and myc oncogenes in human solid tumours and their relevance in diagnosis and prognosis (review).
Field JK; Spandidos DA
Anticancer Res; 1990; 10(1):1-22. PubMed ID: 2185684
[TBL] [Abstract][Full Text] [Related]
14. Low expression of long noncoding XLOC_010588 indicates a poor prognosis and promotes proliferation through upregulation of c-Myc in cervical cancer.
Liao LM; Sun XY; Liu AW; Wu JB; Cheng XL; Lin JX; Zheng M; Huang L
Gynecol Oncol; 2014 Jun; 133(3):616-23. PubMed ID: 24667250
[TBL] [Abstract][Full Text] [Related]
15. Oncogene expression in cervical intraepithelial neoplasia and invasive cancer of cervix.
Pinion SB; Kennedy JH; Miller RW; MacLean AB
Lancet; 1991 Apr; 337(8745):819-20. PubMed ID: 1672915
[TBL] [Abstract][Full Text] [Related]
16. No correlation between ras, c-myc and c-jun proto-oncogene expression and prognosis in advanced carcinoma of cervix.
Symonds RP; Habeshaw T; Paul J; Kerr DJ; Darling A; Burnett RA; Sotsiou F; Linardopoulos S; Spandidos DA
Eur J Cancer; 1992; 28A(10):1615-7. PubMed ID: 1389474
[TBL] [Abstract][Full Text] [Related]
17. [Gene diagnosis of uterine cervical cancer].
Nagai N
Rinsho Byori; 1994 Apr; 42(4):372-9. PubMed ID: 7909855
[TBL] [Abstract][Full Text] [Related]
18. Oncogenes in gynecologic malignancy.
Baker V
Curr Opin Obstet Gynecol; 1992 Feb; 4(1):75-80. PubMed ID: 1543833
[TBL] [Abstract][Full Text] [Related]
19. High human papillomavirus oncogene mRNA expression and not viral DNA load is associated with poor prognosis in cervical cancer patients.
de Boer MA; Jordanova ES; Kenter GG; Peters AA; Corver WE; Trimbos JB; Fleuren GJ
Clin Cancer Res; 2007 Jan; 13(1):132-8. PubMed ID: 17200347
[TBL] [Abstract][Full Text] [Related]
20. HPV induced cervical carcinogenesis: molecular basis and vaccine development.
Kaufmann AM; Backsch C; Schneider A; Dürst M
Zentralbl Gynakol; 2002 Nov; 124(11):511-24. PubMed ID: 12796844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
